We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration

News   Apr 19, 2012

 
Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration
 
 
Advertisement
 

RELATED ARTICLES

Viral “Molecular Scissor” Identified as a Potential COVID-19 Drug Target

News

Researchers develop a new approach to targeting SARS-CoV-2, by blocking a molecular “scissor” known as SARS-CoV-2-PLpro that the virus uses for virus production.

READ MORE

Scientists Begin To Unravel the Complexity of DNA Enhancers

News

In an attempt to learn more about DNA enhancers, the Crocker group from EMBL Heidelberg performed an extensive study, published in Nature, on a specific enhancer in the model organism Drosophila melanogaster, a species of fruit fly.

READ MORE

Novel Therapeutic Vaccine Against Leukemia Developed

News

Researchers from the Institute of Process Engineering (IPE) of Chinese Academy of Sciences and Zhujiang Hospital of Southern Medical University have developed a new type of precise therapeutic vaccine against leukemia. It utilizes self-healing polylactic acid microcapsules for co-encapsulating a new epitope peptide and PD-1 antibody.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE